HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.

AbstractAIM:
Small intestine-derived chylomicrons and chylomicron remnants, which are predominant in patients with postprandial hypertriglyceridemia, chylomicron syndrome and/or familial dyslipidemia, carry one molecule of apolipoprotein B-48(apo B-48) per lipoprotein particle. We investigated the reference interval for the apo B-48 concentration.
METHODS:
We studied 516 individuals who provided written informed consent and confirmed that they were not taking any medications. BMI, waist circumference, blood pressure and the fasting serum concentrations of LDL-C, triglyceride(TG), HDL-C and apo B-48 were measured. The Apo B-48 concentrations were compared according to sex, a pre- or postmenopausal status, dyslipidemia(LDL-C ≥140 mg/dL, TG ≥150 mg/dL, HDL-C <40 mg/dL), metabolic syndrome(MetS) and the number of risk factors.
RESULTS:
The fasting apo B-48 concentrations(mean±SD) were significantly higher in men than in women(3.8±3.3 μg/mL vs 2.4±1.9 μg/mL, p<0.001), subjects with a BMI of ≥25 kg/m(2) versus a BMI of <25 kg/m(2) (4.4±3.7 μg/mL vs 2.8±2.4 μg/mL, p<0.001) and those with versus without MetS(6.5±4.3 μg/mL vs 3.0±2.6 μg/mL, p<0.001). High apo B-48 concentrations were also observed in correlation with the number of risk factors for the MetS. The upper reference limit of apo B-48 was estimated to be 5.7 μg/mL among the 332 patients with normolipidemia, excluding those exhibiting a mean value above ±2.58 standard deviations(SDs), as the mean and range of mean ±1.96 SD were calculated to be 2.04 μg/mL(reference value) and 0.74 to 5.65 μg/mL(reference interval), respectively.
CONCLUSIONS:
Based on our study of normolipidemic patients, the upper reference limit for the fasting apo B-48 concentration is estimated to be 5.7 μg/mL.
AuthorsDaisaku Masuda, Makoto Nishida, Toshihiko Arai, Hiroyuki Hanada, Hiroshi Yoshida, Keiko Yamauchi-Takihara, Toshiki Moriyama, Norio Tada, Shizuya Yamashita
JournalJournal of atherosclerosis and thrombosis (J Atheroscler Thromb) Vol. 21 Issue 6 Pg. 618-27 ( 2014) ISSN: 1880-3873 [Electronic] Japan
PMID24573016 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein B-48
Topics
  • Aged
  • Apolipoprotein B-48 (blood)
  • Asian People
  • Blood Pressure
  • Body Mass Index
  • Dose-Response Relationship, Drug
  • Dyslipidemias (blood, metabolism)
  • Fasting
  • Female
  • Humans
  • Japan
  • Male
  • Metabolic Syndrome (blood)
  • Middle Aged
  • Postmenopause
  • Postprandial Period
  • Premenopause
  • Reference Values
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: